There's More to Gilead Sciences' Remdesivir Data Than Meets the Eye - Motley Fool

1. There's More to Gilead Sciences' Remdesivir Data Than Meets the Eye  Motley Fool
2. Drug used to treat Ebola may help COVID-19 patients, preliminary results suggest  Livescience.com
3. BMO downgrades Gilead over concerns about commercial promise of remdesivir  MarketWatch
4. Gilead Stock Rallied on Covid-19 Drug Hopes. This Is as Good as It Gets, Analysts Say.  Barron's
5. Gilead Sciences: Possible COVID-19 Treatment Already Priced in the Stock, Says Analyst  Yahoo Finance
6. View Full Coverage on Google News

by via Top stories - Google News